1. Home
  2. PACB vs BACQ Comparison

PACB vs BACQ Comparison

Compare PACB & BACQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PACB
  • BACQ
  • Stock Information
  • Founded
  • PACB 2000
  • BACQ 2024
  • Country
  • PACB United States
  • BACQ United States
  • Employees
  • PACB N/A
  • BACQ N/A
  • Industry
  • PACB Biotechnology: Laboratory Analytical Instruments
  • BACQ
  • Sector
  • PACB Industrials
  • BACQ
  • Exchange
  • PACB Nasdaq
  • BACQ NYSE
  • Market Cap
  • PACB 364.2M
  • BACQ 347.7M
  • IPO Year
  • PACB 2010
  • BACQ 2024
  • Fundamental
  • Price
  • PACB $1.57
  • BACQ N/A
  • Analyst Decision
  • PACB Buy
  • BACQ
  • Analyst Count
  • PACB 9
  • BACQ 0
  • Target Price
  • PACB $2.06
  • BACQ N/A
  • AVG Volume (30 Days)
  • PACB 11.0M
  • BACQ 90.0K
  • Earning Date
  • PACB 08-06-2025
  • BACQ 01-01-0001
  • Dividend Yield
  • PACB N/A
  • BACQ N/A
  • EPS Growth
  • PACB N/A
  • BACQ N/A
  • EPS
  • PACB N/A
  • BACQ N/A
  • Revenue
  • PACB $152,357,000.00
  • BACQ N/A
  • Revenue This Year
  • PACB $3.33
  • BACQ N/A
  • Revenue Next Year
  • PACB $18.52
  • BACQ N/A
  • P/E Ratio
  • PACB N/A
  • BACQ $114.40
  • Revenue Growth
  • PACB N/A
  • BACQ N/A
  • 52 Week Low
  • PACB $0.85
  • BACQ $9.80
  • 52 Week High
  • PACB $2.72
  • BACQ $10.45
  • Technical
  • Relative Strength Index (RSI)
  • PACB 72.41
  • BACQ N/A
  • Support Level
  • PACB $1.20
  • BACQ N/A
  • Resistance Level
  • PACB $1.35
  • BACQ N/A
  • Average True Range (ATR)
  • PACB 0.12
  • BACQ 0.00
  • MACD
  • PACB 0.03
  • BACQ 0.00
  • Stochastic Oscillator
  • PACB 92.16
  • BACQ 0.00

About PACB Pacific Biosciences of California Inc.

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

About BACQ BLEICHROEDER ACQUISITION CORP. I

Bleichroeder Acquisition Corp I is a blank check company.

Share on Social Networks: